Oxford University Press

SHERPA: Yellow

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Mellinghoff
    Mellinghoff
  4. Shuman
    Shuman
  5. Rosenblum
    Rosenblum
  6. Dunkel
    Dunkel
  7. Karajannis
    Karajannis
  8. Saltz
    Saltz
  9. Souweidane
    Souweidane
  10. Panageas
    Panageas

Groups

  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)
  7. Department of Pathology and Laboratory Medicine (415)
  8. Gastrointestinal Oncology Service (386)
  9. Genitourinary Oncology Service (367)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2107)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (92)
  5. Editorial (84)
  6. Guidelines (36)
  7. Correspondence (26)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (10)
Groups
  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Stewart Shuman (88)
  6. Marc Rosenblum (87)

More People

Years
  1. 2025 (105)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1670)
  2. Neuro-Oncology (846)
  3. JNCI: Journal of the National Cancer Institute (485)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (138)
  6. American Journal of Clinical Pathology (106)

More Publications

Results (4652)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multiplex microsphere PCR (mmPCR) allows simultaneous gram typing, detection of fungal DNA, and antibiotic resistance genes
    Journal Article

    Browne, D. J.; Liang, F.; Gartlan, K. H.; Harris, P. N. A.; Hill, G. R.; Corrie, S. R.; Markey, K. A.
    Laboratory Medicine (2022)

    Fulltext@MSK | Save
  • Health economics research in cancer treatment: Current challenges and future directions
    Review

    Yu, J. B.; Schrag, D.; Robin Yabroff, K.
    Journal of the National Cancer Institute - Monographs (2022)

    Fulltext@MSK | Save
  • Impact of letermovir primary cytomegalovirus prophylaxis on 1-year mortality after allogeneic hematopoietic cell transplantation: A retrospective cohort study
    Journal Article

    Su, Y.; Stern, A.; Karantoni, E.; Nawar, T.; Han, G.; Zavras, P.; Dumke, H.; Cho, C.; Tamari, R.; Shaffer, B.; more...
    Clinical Infectious Diseases (2022)

    Fulltext@MSK | Save
  • Permanent carrier-embedded Cesium-131 brachytherapy for the salvage treatment of previously irradiated, recurrent brain metastases
    Meeting Abstract

    Imber, B. S.; Beal, K.; Reiner, A. S.; Giantini-Larsen, A.; Yang, J. T.; Aramburu-Nunez, D.; Cohen, G.; Brennan, C.; Tabar, V.; Young, R. J.; more...
    Neuro-Oncology Advances (2022)

    Fulltext@MSK | Save
  • Intracranial activity of tepotinib in patients with MET exon 14 (METex14) skipping NSCLC enrolled in vision
    Meeting Abstract

    Leighl, N.; Bestvina, C.; Patel, J.; Le, X.; Veillon, R.; Anderson, I.; Demedts, I.; Garassino, M. C.; Mazières, J.; Morise, M.; more...
    Neuro-Oncology Advances (2022)

    Fulltext@MSK | Save
  • Trial in progress: A phase 1B/2 study of GB5121, a novel, highly selective, potent, and CNS-penetrant inhibitor of Bruton’s tyrosine kinase (BTKI) for relapsed/refractory primary/secondary CNS lymphoma (R/R PCNSL/SCNSL) and primary vitreoretinal lymphoma (PVRL)
    Meeting Abstract

    Soussain, C.; Grommes, C.; Issa, S.; Ward, R.; Peterson, C.; Cravets, M.; Mathias, A.; Sosa, J.; Kirby, B.; Ding, Z.; more...
    Neuro-Oncology Advances (2022)

    Fulltext@MSK | Save
  • Neurocognitive function in patients with leptomeningeal metastasis treated with proton craniospinal irradiation
    Meeting Abstract

    Correa, D.; Koch, A.; Baser, R.; Pentsova, E.; Wolden, S.; Imber, B.; Boire, A.; Yang, J.
    Neuro-Oncology Advances (2022)

    Fulltext@MSK | Save
  • Breast to brain metastasis is exacerbated with chemotherapy through blood-cerebral spinal fluid-barrier and induces Alzheimer’s-like pathology
    Meeting Abstract

    Neman, J.; Saatian, B.; Herrera, R.; Martirosian, V.; Eisenbarth, R.; Iyer, M.; Julian, A.; Lowman, A.; LaViolette, P.; Remsik, J.; more...
    Neuro-Oncology Advances (2022)

    Fulltext@MSK | Save
  • Integrated team-based brain metastasis care reduces patient visits and shortens time to adjuvant irradiation
    Meeting Abstract

    Moss, N. S.; El Ahmadieh, T. Y.; Brown, S.; Chen, J.; Imber, B. S.; Pike, L.; Reiner, A. S.; Panageas, K. S.; Brennan, C.; Tabar, V.; more...
    Neuro-Oncology Advances (2022)

    Fulltext@MSK | Save
  • Phase I study of concurrent paxalisib and radiation therapy in patients with solid tumor brain metastases or leptomeningeal metastases harboring PI3K pathway mutations: Results from the dose-escalation cohort
    Meeting Abstract

    Yang, J.; Mann, J.; Pike, L.; Zinovoy, M.; Young, R.; Offin, M.; Mitchell, R.; Kazarian, A.; Shadat, T.; Garner, J.; more...
    Neuro-Oncology Advances (2022)

    Fulltext@MSK | Save